Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort studyResearch in context

Summary: Background: COPD is an established risk factor for lung cancer. Sleep apnoea is prevalent in COPD and the inflammation caused by intermittent hypoxaemia may increase this lung cancer risk. Females have more systemic inflammation for a similar apnoea-hypopnoea index than males. Therefore, t...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristiaan Proesmans, Annemarie I. Luik, Lies Lahousse
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:The Lancet Regional Health. Europe
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776225000614
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849339212774506496
author Kristiaan Proesmans
Annemarie I. Luik
Lies Lahousse
author_facet Kristiaan Proesmans
Annemarie I. Luik
Lies Lahousse
author_sort Kristiaan Proesmans
collection DOAJ
description Summary: Background: COPD is an established risk factor for lung cancer. Sleep apnoea is prevalent in COPD and the inflammation caused by intermittent hypoxaemia may increase this lung cancer risk. Females have more systemic inflammation for a similar apnoea-hypopnoea index than males. Therefore, this study aims to investigate sex-specific associations between sleep apnoea and lung cancer in COPD. Methods: The sex-specific absolute and relative risk of sleep apnoea on newly diagnosed lung cancer was estimated in a nationwide observational study of Belgian patients with COPD (≥55 years), between 2017 and 2022, using an Aalan-Johanson estimator and a cause-specific Cox regression model adjusted for age, socioeconomic status, smoking status, alcoholism, frailty, comorbidities, and comedication. Findings: The study consisted of 62,903 COPD patients (42·80% female), of whom 2898 (4·60%) developed lung cancer. We found a significant sex interaction of sleep apnoea on lung cancer hazard (χ-squared: 13·239, P-interaction < 0·01). In females, sleep apnoea was associated with a higher lung cancer risk (cumulative incidence: 1545 vs 1350 per 100,000 PY; aHR: 1·31 (95% CI: 1·05–1·63)). For males, sleep apnoea patients had a lower lung cancer risk (cumulative incidence: 1632 and 2305 per 100,000 PY; aHR: 0·82 (95% CI: 0·70–0·95)). The impact of sleep apnoea on lung cancer development was especially strong in female COPD patients with hypoxia-related comorbidities e.g., with a history of emphysema (aHR: 2·65 (95% CI: 1·11–6·34)). Interpretation: Sleep apnoea was associated with a higher risk of lung cancer in female COPD patients while, in males, there was a lower risk. Especially in female COPD patients with hypoxia, sleep apnoea is strongly associated with an increased lung cancer risk. Funding: Emmanuel van der Schueren cancer research fellowship “Kom Op Tegen Kanker”.
format Article
id doaj-art-8efcf368d17c46c48ee48a0d25d5184f
institution Kabale University
issn 2666-7762
language English
publishDate 2025-05-01
publisher Elsevier
record_format Article
series The Lancet Regional Health. Europe
spelling doaj-art-8efcf368d17c46c48ee48a0d25d5184f2025-08-20T03:44:11ZengElsevierThe Lancet Regional Health. Europe2666-77622025-05-015210126910.1016/j.lanepe.2025.101269Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort studyResearch in contextKristiaan Proesmans0Annemarie I. Luik1Lies Lahousse2Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, BelgiumDepartment of Epidemiology, Erasmus Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015, the Netherlands; Trimbos Institute, The Netherlands Institute of Mental Health and Addiction, Utrecht, the NetherlandsDepartment of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Belgium; Department of Epidemiology, Erasmus Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015, the Netherlands; Corresponding author. Department of Bioanalysis, Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Belgium.Summary: Background: COPD is an established risk factor for lung cancer. Sleep apnoea is prevalent in COPD and the inflammation caused by intermittent hypoxaemia may increase this lung cancer risk. Females have more systemic inflammation for a similar apnoea-hypopnoea index than males. Therefore, this study aims to investigate sex-specific associations between sleep apnoea and lung cancer in COPD. Methods: The sex-specific absolute and relative risk of sleep apnoea on newly diagnosed lung cancer was estimated in a nationwide observational study of Belgian patients with COPD (≥55 years), between 2017 and 2022, using an Aalan-Johanson estimator and a cause-specific Cox regression model adjusted for age, socioeconomic status, smoking status, alcoholism, frailty, comorbidities, and comedication. Findings: The study consisted of 62,903 COPD patients (42·80% female), of whom 2898 (4·60%) developed lung cancer. We found a significant sex interaction of sleep apnoea on lung cancer hazard (χ-squared: 13·239, P-interaction < 0·01). In females, sleep apnoea was associated with a higher lung cancer risk (cumulative incidence: 1545 vs 1350 per 100,000 PY; aHR: 1·31 (95% CI: 1·05–1·63)). For males, sleep apnoea patients had a lower lung cancer risk (cumulative incidence: 1632 and 2305 per 100,000 PY; aHR: 0·82 (95% CI: 0·70–0·95)). The impact of sleep apnoea on lung cancer development was especially strong in female COPD patients with hypoxia-related comorbidities e.g., with a history of emphysema (aHR: 2·65 (95% CI: 1·11–6·34)). Interpretation: Sleep apnoea was associated with a higher risk of lung cancer in female COPD patients while, in males, there was a lower risk. Especially in female COPD patients with hypoxia, sleep apnoea is strongly associated with an increased lung cancer risk. Funding: Emmanuel van der Schueren cancer research fellowship “Kom Op Tegen Kanker”.http://www.sciencedirect.com/science/article/pii/S2666776225000614Sleep apnoeaCOPDLung cancer
spellingShingle Kristiaan Proesmans
Annemarie I. Luik
Lies Lahousse
Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort studyResearch in context
The Lancet Regional Health. Europe
Sleep apnoea
COPD
Lung cancer
title Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort studyResearch in context
title_full Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort studyResearch in context
title_fullStr Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort studyResearch in context
title_full_unstemmed Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort studyResearch in context
title_short Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort studyResearch in context
title_sort sex specific associations between sleep apnoea and lung cancer risk in patients with copd a nationwide prospective cohort studyresearch in context
topic Sleep apnoea
COPD
Lung cancer
url http://www.sciencedirect.com/science/article/pii/S2666776225000614
work_keys_str_mv AT kristiaanproesmans sexspecificassociationsbetweensleepapnoeaandlungcancerriskinpatientswithcopdanationwideprospectivecohortstudyresearchincontext
AT annemarieiluik sexspecificassociationsbetweensleepapnoeaandlungcancerriskinpatientswithcopdanationwideprospectivecohortstudyresearchincontext
AT lieslahousse sexspecificassociationsbetweensleepapnoeaandlungcancerriskinpatientswithcopdanationwideprospectivecohortstudyresearchincontext